Webster, R., Cho, M., Retterer, K., Millan, F., Nowak, C., Douglas, J., . . . Chung, W. (2017). De novo loss of function mutations in KIAA2022 are associated with epilepsy and neurodevelopmental delay in females. Clinical Genetics, 91(5), 756. https://doi.org/10.1111/cge.12854
Chicago Style (17th ed.) CitationWebster, R., et al. "De Novo Loss of Function Mutations in KIAA2022 Are Associated with Epilepsy and Neurodevelopmental Delay in Females." Clinical Genetics 91, no. 5 (2017): 756. https://doi.org/10.1111/cge.12854.
MLA (9th ed.) CitationWebster, R., et al. "De Novo Loss of Function Mutations in KIAA2022 Are Associated with Epilepsy and Neurodevelopmental Delay in Females." Clinical Genetics, vol. 91, no. 5, 2017, p. 756, https://doi.org/10.1111/cge.12854.